Abstract
BackgroundRisk prediction models estimate the risk of developing future outcomes for individuals based on one or more underlying characteristics (predictors). We review how researchers develop and validate risk prediction models within an individual participant data (IPD) meta-analysis, in order to assess the feasibility and conduct of the approach.MethodsA qualitative review of the aims, methodology, and reporting in 15 articles that developed a risk prediction model using IPD from multiple studies.ResultsThe IPD approach offers many opportunities but methodological challenges exist, including: unavailability of requested IPD, missing patient data and predictors, and between-study heterogeneity in methods of measurement, outcome definitions and predictor effects. Most articles develop their model using IPD from all available studies and perform only an internal validation (on the same set of data). Ten of the 15 articles did not allow for any study differences in baseline risk (intercepts), potentially limiting their model’s applicability and performance in some populations. Only two articles used external validation (on different data), including a novel method which develops the model on all but one of the IPD studies, tests performance in the excluded study, and repeats by rotating the omitted study.ConclusionsAn IPD meta-analysis offers unique opportunities for risk prediction research. Researchers can make more of this by allowing separate model intercept terms for each study (population) to improve generalisability, and by using ‘internal-external cross-validation’ to simultaneously develop and validate their model. Methodological challenges can be reduced by prospectively planned collaborations that share IPD for risk prediction.
Highlights
Risk prediction models estimate the risk of developing future outcomes for individuals based on one or more underlying characteristics
Noordzij et al [5] state “parathyroid hormone (PTH) assay, when checked 1 to 6 hours after thyroidectomy, has excellent accuracy in determining which patients will become symptomatically hypocalcemic”, whilst Yap et al [35] state “our study suggests that in post-myocardial infarction (MI) patients, pre-selected using LVEF or frequent ventricular premature beats, the additional use of a simple prognostic indicator based on demographic and baseline information was able to segregate patients that were at high risk of dying, for 3 different modes of mortality”
Our review highlights that the individual participant data (IPD) meta-analysis approach is highly appealing, as it allows the use of internal-external cross validation to develop a model and simultaneously evaluate its performance across multiple populations
Summary
Risk prediction models estimate the risk of developing future outcomes for individuals based on one or more underlying characteristics (predictors). For example individuals who are seemingly healthy but are found to have a high risk of developing cardiovascular disease could be recommended to modify their lifestyle and behaviour (e.g. smoking, exercise, eating habits) to reduce their future risk They may be prioritised for clinical investigation, which could lead to early diagnosis of an underlying condition (e.g. diabetes, high blood pressure) and preventative treatment (e.g. statins or aspirin) to manage it. For this purpose of prognostic risk assessments there is a growing interest in risk prediction modelling, [1,2,3] where a statistical model is used to estimate the risk of future outcomes for individuals based on one or more underlying characteristics. The outcomes being predicted were either general (e.g. mortality) or disease-specific (e.g. development of radiation myelopathy, fatal coronary heart disease within 10 years, postoperative symptomatic hypocalcemia) (Table 1)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.